Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Halifax, Boston MA, Providence RI, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase 3, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
for
Dravet Syndrome
Location: New Haven CT, Marlboro NJ, Philadelphia PA, Ottawa,
Sponsor: Epygenix
Sex: All
Age: 2+
Code: NCT04462770
Phase 3, Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Jacksonville NC, Goldsboro NC, Clinton NC,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Saint John, Bath ME, Portland ME, Scarborough ME,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Levis, Quebec, New York NY, Montreal, Annapolis MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase 3, Recruiting
Pan Tumor Rollover Study
for
Cancer
Location: Boston MA, Mineola NY, Lancaster PA, Toronto,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT03899155
Phase 2, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Boston MA, Hartford CT, New Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase 2, Recruiting
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Plantation FL, Canton OH, Lexington KY
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Sex: All
Age: 18 - 70+
Code: NCT06592638
Phase 1, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Baltimore MD, Columbia SC, Louisville KY, Dallas TX,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study